Nuclear Radiology: Page 64

SNM: PET/CT predicts colorectal cancer outcomes
By AuntMinnieEurope.com staff writers
Careful monitoring of colorectal cancer patients with PET/CT during initial treatment can predict outcomes, potentially improving success rates while reducing treatment costs, Italian researchers reported at this week's Society of Nuclear Medicine (SNM) meeting in Miami Beach, FL.
June 11, 2012
ITG, NTP cooperate on global radioisotope production
By AuntMinnieEurope.com staff writers
ITG Isotope Technologies Garching and NTP Radioisotopes, a subsidiary of the South African Nuclear Energy Corporation, announced that they will collaborate to guarantee that Brazil and African countries will have a reliable supply of high quality radioisotopes.
June 11, 2012
SNM: New therapy extends life for prostate cancer patients
By AuntMinnieEurope.com staff writers
Survival is bleak for prostate cancer patients with advanced tumors that have spread to the bone, but a radioisotope procedure being evaluated in a clinical trial is extending lives by several months, according to a study presented at the Society of Nuclear Medicine (SNM) annual meeting, being held in Miami Beach, FL, this week.
June 10, 2012
GE, Affibody to develop PET imaging agent
By AuntMinnieEurope.com staff writers
GE Healthcare and Swedish biopharmaceutical company Affibody are collaborating on the development of a HER2-targeted PET imaging agent for patients with breast or gastric cancer.
June 4, 2012
Dilon promotes declipseSPECT study results
By AuntMinnieEurope.com staff writers
Breast-specific gamma imaging developer Dilon Diagnostics is highlighting clinical research regarding its declipseSPECT device presented in March at the Society of Surgical Oncology annual cancer symposium.
May 8, 2012
Study: SPECT/CT finds 1-mm pancreatic cancers
By AuntMinnieEurope.com staff writers
By using 2D/3D SPECT/CT, Swiss researchers have detected a drug bound to insulinoma cells, indicating the precise location of life-threatening pancreatic tumors as small as about 1 mm in diameter.
May 7, 2012
Eckert & Ziegler posts Q1 growth
By AuntMinnieEurope.com staff writers
Radiotherapy developer Eckert & Ziegler reported positive results in the first quarter of 2012 (end-March 30).
May 2, 2012
Eckert & Ziegler builds cyclotron in Warsaw
By AuntMinnieEurope.com staff writers
Radiotherapy developer Eckert & Ziegler said it has begun construction of a new cyclotron facility to manufacture PET radiopharmaceuticals in Warsaw.
April 29, 2012
GE, Swedish firm collaborate on radiotracer program
By AuntMinnieEurope.com staff writers
GE Healthcare and Swedish venture capital firm NXT2B have signed a joint financing agreement to develop a microscale radiotracer infrastructure that includes a cyclotron and PET tracer production.
April 18, 2012
CERN fosters collaboration for medical advances
By Tami Freeman, PhD
CERN, the European Organization for Nuclear Research, is renowned for its pioneering research in fundamental physics -- investigating the origins of the universe and how it works. Some of its tools, such as particle accelerators and advanced detectors, also play an invaluable role in diagnostic and therapeutic medicine.
April 5, 2012
2012 04 05 11 29 38 69 2012 04 06 Cern Thumb
Comecer acquires Veenstra Instruments
By AuntMinnieEurope.com staff writers
Italian shielding systems firm Comecer has acquired Veenstra Instruments.
April 4, 2012
IBA Molecular deal finalized
By AuntMinnieEurope.com staff writers
Ion Beam Applications (IBA) and SK Capital Partners, a New York City-based private investment firm, announced they have successfully completed their agreement to create IBA Molecular, a jointly owned company derived from IBA's worldwide radiopharmaceutical division.
April 1, 2012
Previous Page
Page 64 of 90
Next Page